MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A unique phenotype associated with anti-GAD antibodies

A.P. Mentreddi, S. Chitnis, P. Khemani (Dallas, TX, USA)

Meeting: 2016 International Congress

Abstract Number: 1078

Keywords: Ataxia: Clinical features, Dystonia: Etiology and Pathogenesis, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Ataxia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To describe a case of hemiatiaxia, parkinsonism, and dystonia associated with anti-Glutamic Acid Decarboxylase (GAD) antibodies.

Background: GAD antibodies have been implicated in endocrinopathies and a variety of neurological manifestations including stiff person syndrome, cerebellar ataxia, epilepsy, and limbic encephalitis with and without a paraneoplastic syndrome. We aim to describe a case of an asymmetric movement disorder in a patient with anti-GAD antibodies.

Methods: A 65-year-old Indian woman, recently diagnosed with insulin-dependent Diabetes Mellitus, presented with a 1-year history of progressive gait impairment requiring use of a walker and right-hand tremor, clumsiness, and posturing. Neurological examination was remarkable for saccadic smooth pursuit and impaired vertical gaze; dysarthria; and right-sided rigidity, bradykinesia, rest tremor, dysmetria, dysdiadochokinesia, and dystonia. Stance was wide based, balance was impaired, and gait was slow, ataxic and showed right foot dystonia. Cortical signs such as apraxia and agraphesthesia were absent.

Results: Diagnostic investigation for treatable causes of ataxia revealed high titers of anti-GAD antibodies in serum (566 nmol/L, normal ≤ 0.02 nmol/L) and CSF (30.3 nmol/L, normal ≤ 0.02 nmol/L). Brain MRI showed cerebellar vermian atrophy. CT scans of the chest, abdomen, and pelvis showed no evidence of malignancy. She was admitted to hospital for plasma exchange followed by IV Rituximab with mild improvement in symptoms. IV Rituximab every 6 months and physical therapy were continued.

Conclusions: Anti-GAD syndromes can present heterogeneously. A combination of asymmetric dystonia, parkinsonism, and ataxia associated with anti-GAD antibodies has not been previously reported based on our review of the literature. This case illustrates the importance of considering anti-GAD antibody syndrome, a potentially treatable condition, in patients with an otherwise unexplained complex movement disorder to facilitate prompt diagnosis and treatment.

To cite this abstract in AMA style:

A.P. Mentreddi, S. Chitnis, P. Khemani. A unique phenotype associated with anti-GAD antibodies [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/a-unique-phenotype-associated-with-anti-gad-antibodies/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-unique-phenotype-associated-with-anti-gad-antibodies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley